Aegerion Pharmaceuticals (AEGR)

Add to Watchlists
Create an Alert
22.87 +0.06  +0.26% NASDAQ Dec 22, 5:00PM BATS Real time Currency in USD
View Full Chart
AEGR Price Chart
View All Events

AEGR Events

Date Type Description
11/06/2014 Misc Investor Call: Aegerion Acquires Myalept From Astrazeneca
10/30/2014 17:00 EDT Misc Q3 2014 Aegerion Pharmaceuticals Earnings Conference Call
10/30/2014 Earnings Q3 2014 Aegerion Pharmaceuticals Earnings Results
07/29/2014 17:00 EDT Misc Aegerion Pharmaceuticals Inc 2014 Second Quarter Earnings Conference Call
07/29/2014 Earnings Aegerion Pharmaceuticals Announces Second-Quarter 2014 Financial Results
06/25/2014 Misc Annual General Meeting for Aegerion Pharmaceuticals Inc
05/06/2014 17:00 EDT Misc Aegerion Pharmaceuticals Inc Q1 2014 Earnings Conference Call
05/06/2014 Earnings Aegerion Pharmaceuticals Inc Q1 2014 Earnings Results
02/26/2014 08:30 EST Misc Aegerion Pharmaceuticals, Inc. Earnings Conference Call
02/26/2014 Earnings Aegerion Pharmaceuticals, Inc. Earnings Results
View All Performance Charts

AEGR Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Aegerion Pharmaceuticals is down 64.45% over the last year vs S&P 500 Total Return up 17.26%, Celladon up N/A, and Trevena up N/A.

Get Quote for
Advertisement

Portfolio Strategies Featuring AEGR

Did Aegerion Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

AEGR Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.aegerion.com
  • IR Website: http://ir.aegerion.com/
  • HQ Country: United States
  • HQ State/Province: Massachusetts
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: December 31, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: September 30, 2014
  • Last Fiscal Year End: December 31, 2013
  • Next Earnings Release: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Aegerion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company currently operates in one business segment focusing on the development and commercialization of its product, lomitapide.

AEGR Excel Add-In Codes

  • Name: =YCI("AEGR","name")
  • Description: =YCI("AEGR","description")
  • Sector: =YCI("AEGR","sector")
  • Industry: =YCI("AEGR","industry")
  • Est. Current Fiscal Year End: =YCI("AEGR","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.